The Beat HLTH: Geoff Cook & Cody Fair on Transforming Chronic Disease Management with AI and GLP-1 Innovations
About Geoff Cook:
Geoff Cook is a seasoned entrepreneur and the CEO of Noom, with a proven track record of driving innovation and growth. As the former CEO of The Meet Group, he led the NASDAQ-listed company to a $500 million acquisition in 2020, building a live-streaming and creator economy revenue stream exceeding $200 million annually. Geoff spearheaded industry consolidation by acquiring and integrating four companies into a cohesive, efficient culture. A Harvard Economics graduate, he has deep expertise in scaling platforms, leveraging technology to enhance user experiences, and creating enterprise solutions like Livebox, which powers top-grossing social apps globally.
About Cody Fair:
As Head of Employer Sales at Noom, Cody Fair leads a team focused on helping brokers, consultants, and enterprise employers transform lives through Noom’s blend of psychology, technology, and coaching. Passionate about continuous improvement, Cody emphasizes the importance of refining sales and leadership skills through ongoing learning and development. By fostering a growth mindset within the team, he ensures a focus on controllable factors to drive success. There’s nothing more fulfilling to Cody than inspiring others to embrace this mentality and achieve their personal and professional goals.
Things You’ll Learn:
- New programs provide employers with cost-effective ways to offer GLP-1 medications, reducing financial barriers for both employers and employees.
- GLP-1 medications work best when paired with lifestyle adjustments, such as protein tracking and exercise, to prevent muscle loss and long-term health risks.
- Employers can now provide affordable weight management programs through supplemental benefits or employee-paid paths.
- AI-powered tools simplify food tracking, letting users log meals by taking a picture of their plates.
- By focusing on cost-effectiveness and impactful results, these initiatives aim to disrupt high-priced healthcare models.
Resources: